1. Home
  2. CSTM vs ARQT Comparison

CSTM vs ARQT Comparison

Compare CSTM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$25.34

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.21

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTM
ARQT
Founded
2010
2016
Country
France
United States
Employees
12000
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
CSTM
ARQT
Price
$25.34
$25.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$29.00
$25.00
AVG Volume (30 Days)
1.9M
1.1M
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.31
EPS
1.13
N/A
Revenue
$7,335,000,000.00
$196,542,000.00
Revenue This Year
N/A
$86.38
Revenue Next Year
$3.46
$30.29
P/E Ratio
$22.85
N/A
Revenue Growth
N/A
229.74
52 Week Low
$7.33
$11.86
52 Week High
$27.25
$31.77

Technical Indicators

Market Signals
Indicator
CSTM
ARQT
Relative Strength Index (RSI) 64.25 54.73
Support Level $22.32 $26.28
Resistance Level $27.25 $26.97
Average True Range (ATR) 1.23 1.07
MACD -0.01 0.21
Stochastic Oscillator 63.79 82.52

Price Performance

Historical Comparison
CSTM
ARQT

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: